Catalog No.:AA002KYF

210892-23-2 | 1H-Benz[e]indolium, 2-[5-[3-(5-carboxypentyl)-1,3-dihydro-1,1-dimethyl-6,8-disulfo-2H-benz[e]indol-2-ylidene]-1,3-pentadien-1-yl]-3-ethyl-1,1-dimethyl-6,8-disulfo-, inner salt

Name: Name:1H-Benz[e]indolium, 2-[5-[3-(5-carboxypentyl)-1,3-dihydro-1,1-dimethyl-6,8-disulfo-2H-benz[e]indol-2-ylidene]-1,3-pentadien-1-yl]-3-ethyl-1,1-dimethyl-6,8-disulfo-, inner salt
Brand: AABLOCKS
SKU: AA002KYF
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

95%

1 week

$159.00 $112.00

- +

5mg

95%

1 week

$278.00 $195.00

- +

10mg

95%

1 week

$432.00 $303.00

- +

25mg

95%

1 week

$694.00 $486.00

- +

50mg

95%

1 week

$952.00 $667.00

- +

100mg

95%

1 week

$1,292.00 $904.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA002KYF

Chemical Name:

1H-Benz[e]indolium, 2-[5-[3-(5-carboxypentyl)-1,3-dihydro-1,1-dimethyl-6,8-disulfo-2H-benz[e]indol-2-ylidene]-1,3-pentadien-1-yl]-3-ethyl-1,1-dimethyl-6,8-disulfo-, inner salt

CAS Number:

210892-23-2

Molecular Formula:

C41H44N2O14S4

Molecular Weight:

917.0531

MDL Number:

MFCD31560494

SMILES:

CC[N+]1=C(/C=C/C=C/C=C\2/N(CCCCCC(=O)O)c3c(C2(C)C)c2cc(cc(c2cc3)S(=O)(=O)O)S(=O)(=O)O)C(c2c1ccc1c2cc(cc1S(=O)(=O)[O-])S(=O)(=O)O)(C)C

Properties

Literature

Title: Zhu S, et al. Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody. J Drug Target. 2015 Apr;23(3):257-65.

Title: Jiang L, et al. pH/temperature sensitive magnetic nanogels conjugated with Cy5.5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. Biomaterials. 2013 Oct;34(30):7418-28.

Title: Lim B, et al. A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology. Theranostics. 2017 Feb 26;7(5):1047-1061.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS